enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Rifaximin - Wikipedia

   en.wikipedia.org/wiki/Rifaximin

   Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...

3. Does Medicare Cover Rifaximin (Xifaxan)? - AOL

   www.aol.com/lifestyle/does-medicare-cover...

   Most Medicare Part D plans and Part C plans that include drug coverage cover rifaximin (Xifaxan) for irritable bowel syndrome with diarrhea (IBS-D) and overt hepatic encephalopathy (HE). According ...

4. Medicare Part D coverage for Xifaxan - AOL

   www.aol.com/medicare-part-d-coverage-xifaxan...

   Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent ...

5. Travelers' diarrhea - Wikipedia

   en.wikipedia.org/wiki/Travelers'_diarrhea

   Travelers' diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. [ 2 ] [ 3 ] It may be accompanied by abdominal cramps, nausea, fever, headache and bloating. [ 3 ]

6. Rifamycin - Wikipedia

   en.wikipedia.org/wiki/Rifamycin

   The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]

7. Bausch wins US appeal to block Alvogen generic of diarrhea drug

   www.aol.com/news/bausch-wins-us-appeal-block...

   A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029.

8. Escherichia coli - Wikipedia

   en.wikipedia.org/wiki/Escherichia_coli

   Rifaximin, a semisynthetic rifamycin derivative, is an effective and well-tolerated antibacterial for the management of adults with non-invasive traveller's diarrhea. Rifaximin was significantly more effective than placebo and no less effective than ciprofloxacin in reducing the duration of diarrhea.

9. Salix Pharmaceuticals Previews American College of ...

   www.aol.com/news/2012-10-19-salix...

   Salix Pharmaceuticals Previews American College of Gastroenterology 2012 RALEIGH, N.C.--(BUSINESS WIRE)-- Salix Pharmaceuticals, Ltd. (NAS: SLXP) today announced that educational activities and ...